Kiniksa Pharmaceuticals International PLC (KNSA)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Barry D. QuartIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 15.35k | 22.31% |
| 2026-05-29 | Ms. Kimberly J. PopovitsIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 15.35k | 22.31% |
| 2026-06-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 900.00k | 0.00 | Derivative Exercise and Retained Stock | - | 1.14M | 378.53% |
| 2026-05-29 | Ms. Tracey L. McCainIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 15.35k | 22.31% |
| 2026-05-29 | Mr. Thomas R. MalleyIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 15.35k | 22.31% |
| 2026-05-29 | Dr. Richard S. LevyIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 21.96k | 14.61% |
| 2026-05-29 | Mr. Gordon Bradley ColeIndependent Director | 2.80k | 0.00 | Derivative Exercise and Retained Stock | - | 15.35k | 22.31% |
| 2026-05-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -58.42k | 2.53M | Derivative Exercise and Sale | 10.36 - 54.04 | 65.62k | - |
| 2026-05-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -48.57k | 1.12M | Derivative Exercise and Sale | 30.93 - 54.02 | 237.76k | - |
| 2026-04-28 | Mr. Sanj K. PatelCEO & Chairman of the Board | -508.34k | 19.58M | Derivative Exercise and Sale | 10.36 - 54.02 | 237.76k | - |
| 2026-04-28 | Dr. Barry D. QuartIndependent Director | -13.10k | 468.55k | Derivative Exercise and Sale | 14.33 - 50.10 | 12.55k | - |
| 2026-04-09 | Mr. Michael R. MegnaSenior VP & CAO | -6.63k | 309.32k | Automatic Disposition | 46.69 | 27.42k | -19.46% |
| 2026-04-09 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -1.70k | 79.51k | Automatic Disposition | 46.69 | 12.03k | -12.40% |
| 2026-04-07 | Mr. Eben TessariConsultant | 1.88k | 0.00 | Derivative Exercise and Retained Stock | - | 23.13k | 8.85% |
| 2026-04-07 | Mr. Eben TessariConsultant | -846.00 | 41.40k | Derivative Exercise and Sale | 48.94 | 23.13k | - |
| 2026-04-07 | Mr. Mark A. RagosaExec. VP & CFO | 1.39k | 0.00 | Derivative Exercise and Retained Stock | - | 16.15k | 9.42% |
| 2026-04-07 | Mr. Mark A. RagosaExec. VP & CFO | -1.30k | 63.77k | Derivative Exercise and Sale | 48.94 | 16.15k | - |
| 2026-04-07 | Mr. Sanj K. PatelCEO & Chairman of the Board | -4.83k | 236.43k | Sale to Issuer | 48.94 | 237.76k | -1.99% |
| 2026-04-06 | Mr. Sanj K. PatelCEO & Chairman of the Board | -7.28k | 288.57k | Derivative Exercise and Sale | 10.36 - 50.01 | 237.76k | - |
| 2026-04-07 | Mr. Sanj K. PatelCEO & Chairman of the Board | 9.99k | 0.00 | Derivative Exercise and Retained Stock | - | 237.76k | 4.39% |
| 2026-04-07 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 1.29k | 0.00 | Derivative Exercise and Retained Stock | - | 65.62k | 2.00% |
| 2026-04-07 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -1.21k | 59.12k | Derivative Exercise and Sale | 48.94 | 65.62k | - |
| 2026-04-06 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -2.37k | 114.99k | Automatic Disposition | 48.58 | 13.73k | -14.70% |
| 2026-04-07 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -774.00 | 37.88k | Derivative Exercise and Sale | 48.94 | 13.73k | - |
| 2026-04-07 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 1.70k | 0.00 | Derivative Exercise and Retained Stock | - | 13.73k | 14.16% |
| 2026-04-07 | Mr. Michael R. MegnaSenior VP & CAO | -1.67k | 79.87k | Derivative Exercise and Sale | 1.00 - 48.94 | 34.04k | - |
| 2026-04-07 | Mr. Michael R. MegnaSenior VP & CAO | 2.27k | 2.27k | Derivative Exercise and Retained Stock | 1.00 | 34.04k | 7.13% |
| 2026-04-06 | Dr. Barry D. QuartIndependent Director | -6.90k | 246.16k | Derivative Exercise and Sale | 14.33 - 50.00 | 12.55k | - |
| 2026-04-01 | Mr. Eben TessariConsultant | 4.22k | 0.00 | Derivative Exercise and Retained Stock | - | 21.25k | 24.77% |
| 2026-04-01 | Mr. Eben TessariConsultant | -1.76k | 84.52k | Derivative Exercise and Sale | 48.13 | 21.25k | - |
| 2026-04-01 | Mr. Mark A. RagosaExec. VP & CFO | 2.68k | 0.00 | Derivative Exercise and Retained Stock | - | 14.76k | 22.15% |
| 2026-04-01 | Mr. Mark A. RagosaExec. VP & CFO | -2.51k | 120.81k | Derivative Exercise and Sale | 48.13 | 14.76k | - |
| 2026-04-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -10.31k | 496.36k | Derivative Exercise and Sale | 48.13 | 232.60k | - |
| 2026-04-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 11.01k | 0.00 | Derivative Exercise and Retained Stock | - | 232.60k | 4.97% |
| 2026-04-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 3.01k | 0.00 | Derivative Exercise and Retained Stock | - | 64.33k | 4.91% |
| 2026-04-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -2.82k | 135.77k | Derivative Exercise and Sale | 48.13 | 64.33k | - |
| 2026-04-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 4.10k | 0.00 | Derivative Exercise and Retained Stock | - | 14.40k | 39.85% |
| 2026-04-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -1.71k | 82.11k | Derivative Exercise and Sale | 48.13 | 14.40k | - |
| 2026-04-01 | Mr. Michael R. MegnaSenior VP & CAO | 4.36k | 0.00 | Derivative Exercise and Retained Stock | - | 31.78k | 15.90% |
| 2026-04-01 | Mr. Michael R. MegnaSenior VP & CAO | -3.21k | 154.26k | Derivative Exercise and Sale | 48.13 | 31.78k | - |
| 2026-03-09 | Mr. Mark A. RagosaExec. VP & CFO | -36.72k | 926.35k | Derivative Exercise and Sale | 17.76 - 46.24 | 12.09k | - |
| 2026-03-02 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -40.00k | 1.38M | Derivative Exercise and Sale | 10.36 - 45.92 | 61.32k | - |
| 2026-02-10 | Dr. Barry D. QuartIndependent Director | -2.80k | 82.68k | Derivative Exercise and Sale | 15.47 - 45.00 | 12.55k | - |
| 2026-02-09 | Mr. Mark A. RagosaExec. VP & CFO | -10.85k | 315.84k | Derivative Exercise and Sale | 12.97 - 43.72 | 12.09k | - |
| 2026-02-09 | Mr. Mark A. RagosaExec. VP & CFO | -7.00k | 306.04k | Automatic Disposition | 43.72 | 12.09k | -36.68% |
| 2026-02-02 | Dr. Barry D. QuartIndependent Director | -15.96k | 474.73k | Derivative Exercise and Sale | 15.47 - 45.27 | 12.55k | - |
| 2026-02-01 | Dr. Richard S. LevyIndependent Director | 683.00 | 0.00 | Derivative Exercise and Retained Stock | - | 19.16k | 3.70% |
| 2026-01-08 | Mr. Mark A. RagosaExec. VP & CFO | -12.00k | 502.68k | Automatic Disposition | 41.89 | 19.09k | -38.60% |
| 2025-12-15 | Dr. Barry D. QuartIndependent Director | -20.13k | 627.02k | Derivative Exercise and Sale | 10.36 - 41.51 | 12.55k | - |
| 2025-12-15 | Mr. Eben TessariConsultant | -6.00k | 196.38k | Derivative Exercise and Sale | 8.83 - 41.56 | 16.67k | - |
| 2025-12-15 | Mr. Eben TessariConsultant | -6.05k | 251.35k | Automatic Disposition | 41.56 | 16.67k | -26.63% |
| 2025-12-08 | Mr. Mark A. RagosaExec. VP & CFO | -42.84k | 1.29M | Derivative Exercise and Sale | 10.76 - 41.49 | 31.09k | - |
| 2025-11-26 | Mr. Eben TessariConsultant | -200.00 | 4.00k | Derivative Exercise and Sale | 22.89 - 42.89 | 22.71k | - |
| 2025-11-17 | Mr. Eben TessariConsultant | -6.50k | 210.27k | Derivative Exercise and Sale | 8.83 - 41.30 | 22.71k | - |
| 2025-11-17 | Mr. Eben TessariConsultant | -5.97k | 246.56k | Automatic Disposition | 41.30 | 22.71k | -20.81% |
| 2025-11-12 | Mr. Sanj K. PatelCEO & Chairman of the Board | -171.79k | 0.00 | Other Disposition | - | 221.59k | -43.67% |
| 2025-11-12 | Mr. Mark A. RagosaExec. VP & CFO | -19.90k | 199.20k | Derivative Exercise and Sale | 30.93 - 40.94 | 31.09k | - |
| 2025-10-31 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -82.54k | 2.52M | Derivative Exercise and Sale | 3.80 - 37.14 | 61.32k | - |
| 2025-10-28 | Mr. Mark A. RagosaExec. VP & CFO | -100.00 | 1.01k | Derivative Exercise and Sale | 30.93 - 41.00 | 31.09k | - |
| 2025-10-20 | Mr. Sanj K. PatelCEO & Chairman of the Board | -257.97k | 9.04M | Derivative Exercise and Sale | 3.80 - 39.32 | 221.59k | - |
| 2025-10-20 | Mr. Michael R. MegnaSenior VP & CAO | -39.44k | 1.07M | Derivative Exercise and Sale | 10.76 - 39.31 | 27.05k | - |
| 2025-10-20 | Mr. Michael R. MegnaSenior VP & CAO | -11.06k | 434.57k | Automatic Disposition | 39.31 | 27.05k | -29.01% |
| 2025-10-04 | Mr. Michael R. MegnaSenior VP & CAO | 90.00 | 0.00 | Derivative Exercise and Retained Stock | - | 38.10k | 0.24% |
| 2025-10-04 | Mr. Michael R. MegnaSenior VP & CAO | -85.00 | 3.27k | Derivative Exercise and Sale | 38.49 | 38.10k | - |
| 2025-09-29 | Mr. Eben TessariConsultant | -42.00k | 857.22k | Derivative Exercise and Sale | 17.92 - 38.33 | 34.55k | - |
| 2025-09-15 | Mr. Eben TessariConsultant | -6.50k | 179.53k | Derivative Exercise and Sale | 8.83 - 36.45 | 34.55k | - |
| 2025-09-15 | Mr. Eben TessariConsultant | -9.90k | 361.05k | Automatic Disposition | 36.45 - 37.00 | 34.55k | -22.27% |
| 2025-09-04 | Mr. Eben TessariConsultant | -98.66k | 1.98M | Derivative Exercise and Sale | 15.50 - 35.66 | 44.45k | - |
| 2025-09-04 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -3.52k | 124.40k | Automatic Disposition | 35.31 | 9.42k | -27.23% |
| 2025-09-01 | Mr. Eben TessariConsultant | 8.21k | 0.00 | Derivative Exercise and Retained Stock | - | 44.45k | 22.65% |
| 2025-09-03 | Mr. Eben TessariConsultant | -15.09k | 301.82k | Derivative Exercise and Sale | 15.50 - 35.50 | 44.45k | - |
| 2025-09-01 | Mr. Eben TessariConsultant | -3.97k | 133.77k | Sale to Issuer | 33.49 - 34.28 | 44.45k | -8.20% |
| 2025-09-01 | Mr. Michael R. MegnaSenior VP & CAO | 9.63k | 0.00 | Derivative Exercise and Retained Stock | - | 38.01k | 33.92% |
| 2025-09-03 | Mr. Michael R. MegnaSenior VP & CAO | -11.00k | 186.12k | Derivative Exercise and Sale | 17.92 - 34.84 | 38.01k | - |
| 2025-09-01 | Mr. Michael R. MegnaSenior VP & CAO | -4.66k | 156.26k | Sale to Issuer | 33.49 - 34.28 | 38.01k | -10.91% |
| 2025-09-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 3.52k | 0.00 | Derivative Exercise and Retained Stock | - | 12.94k | 37.42% |
| 2025-09-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -3.30k | 110.90k | Derivative Exercise and Sale | 33.49 - 34.28 | 12.94k | - |
| 2025-09-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 3.92k | 0.00 | Derivative Exercise and Retained Stock | - | 61.32k | 6.83% |
| 2025-09-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -3.68k | 123.77k | Derivative Exercise and Sale | 33.49 - 34.28 | 61.32k | - |
| 2025-09-01 | Mr. Mark A. RagosaExec. VP & CFO | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 31.09k | 15.09% |
| 2025-09-01 | Mr. Mark A. RagosaExec. VP & CFO | -3.82k | 128.64k | Derivative Exercise and Sale | 33.49 - 34.28 | 31.09k | - |
| 2025-09-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 15.12k | 0.00 | Derivative Exercise and Retained Stock | - | 221.59k | 7.32% |
| 2025-09-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -14.16k | 476.73k | Derivative Exercise and Sale | 33.49 - 34.28 | 221.59k | - |
| 2025-08-18 | Mr. Eben TessariConsultant | -6.50k | 162.11k | Derivative Exercise and Sale | 8.83 - 33.77 | 40.22k | - |
| 2025-08-18 | Mr. Eben TessariConsultant | -9.70k | 327.64k | Automatic Disposition | 33.77 - 34.44 | 40.22k | -19.43% |
| 2025-08-12 | Mr. Thomas R. MalleyIndependent Director | -177.77k | 4.04M | Derivative Exercise and Sale | 1.86 - 33.32 | 12.55k | - |
| 2025-08-06 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -29.33k | 843.09k | Derivative Exercise and Sale | 3.80 - 32.55 | 57.40k | - |
| 2025-08-05 | Mr. Eben TessariConsultant | -138.61k | 3.02M | Derivative Exercise and Sale | 10.36 - 33.90 | 49.92k | - |
| 2025-08-04 | Mr. Mark A. RagosaExec. VP & CFO | -18.89k | 188.89k | Derivative Exercise and Sale | 22.89 - 32.89 | 27.01k | - |
| 2025-08-04 | Mr. Michael R. MegnaSenior VP & CAO | -17.00k | 286.11k | Derivative Exercise and Sale | 15.52 - 32.35 | 33.04k | - |
| 2025-07-30 | Ms. Kimberly J. PopovitsIndependent Director | -64.51k | 1.16M | Derivative Exercise and Sale | 10.36 - 29.90 | 12.55k | - |
| 2025-07-14 | Mr. Eben TessariConsultant | -6.50k | 129.29k | Derivative Exercise and Sale | 8.83 - 28.72 | 49.16k | - |
| 2025-07-14 | Mr. Eben TessariConsultant | -12.40k | 356.13k | Automatic Disposition | 28.72 | 49.16k | -20.14% |
| 2025-07-01 | Dr. Richard S. LevyIndependent Director | 1.10k | 0.00 | Derivative Exercise and Retained Stock | - | 18.47k | 6.34% |
| 2025-06-16 | Mr. Eben TessariConsultant | -6.50k | 126.43k | Derivative Exercise and Sale | 8.83 - 28.28 | 61.56k | - |
| 2025-06-16 | Mr. Eben TessariConsultant | -10.80k | 305.42k | Automatic Disposition | 28.28 | 61.56k | -14.92% |
| 2025-06-09 | Dr. Barry D. QuartIndependent Director | -27.45k | 728.70k | Derivative Exercise and Sale | 3.80 - 30.39 | 12.55k | - |
| 2025-06-09 | Mr. Eben TessariConsultant | -70.87k | 1.43M | Derivative Exercise and Sale | 10.36 - 30.51 | 72.36k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。